OncoTarget, ‎1949-2553

Journal

Publications

  1. 2014
  2. Published

    Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

    Sarah Kuehne, & , 12 Jan 2014, In: OncoTarget. 5, 7, p. 1761-1769 9 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2013
  4. Published

    Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

    Anthony Kong, Oct 2013, In: OncoTarget. 4, 10, p. 1592-605 14 p.

    Research output: Contribution to journalArticlepeer-review

  5. 2012
  6. Published
  7. 2011
  8. Published
Previous 1 2 3 4 Next